SCHEMBL18919782

SCHEMBL18919782

COc1ccccc1-c1c(C(=O)O)[nH]c2c(C)cccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 7/20 0.65
RPA1 P27694 1/20 0.65
KDM4E B2RXH2 1/20 0.59
MEN1 O00255 1/20 0.59
ALDH1A1 P00352 1/20 0.59
POLB P06746 1/20 0.59
GAA P10253 1/20 0.59
MAPT P10636 1/20 0.59
HPGD P15428 1/20 0.59
TSHR P16473 1/20 0.59
HTT P42858 1/20 0.59
RECQL P46063 1/20 0.59
KMT2A Q03164 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
MAP2 P11137 2/20 0.45
CDC7 O00311 1/20 0.43
MARK3 P27448 1/20 0.43
AXL P30530 1/20 0.43
FRK P42685 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18943456 0.90 MCL1 (0.59) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL29569249 0.90 MCL1 (0.59) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL18919697 0.88 MCL1 (0.78) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL18943417 0.82 MCL1 (0.68) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL29568334 0.82 MCL1 (0.68) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL29568451 0.80 MCL1 (0.65) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL18942982 0.80 MCL1 (0.65) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL3611265 0.79 MCL1 (1.00) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL18919757 0.78 MCL1 (0.75) MCL1RPA1KDM4EMEN1ALDH1A1
SCHEMBL18943636 0.77 MCL1 (0.94) MCL1RPA1KDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11439622-B2 Inhibitors of metallo-beta-lactamases OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2022-09-13 US claimed
CN-108602795-B Inhibitors of metallo-beta-lactamases 牛津大学科技创新有限公司 2022-04-22 CN claimed
US-20200375946-A1 INHIBITORS OF METALLO-BETA-LACTAMASES OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2020-12-03 US claimed
EP-3383858-A1 INHIBITORS OF METALLO-BETA-LACTAMASES Oxford University Innovation Limited (GB) 2018-10-10 EP claimed
CN-108602795-A The inhibitor of metal-beta-lactamase 牛津大学科技创新有限公司 2018-09-28 CN claimed
WO-2017093727-A1 INHIBITORS OF METALLO-BETA-LACTAMASES OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-06-08 WO claimed
CN-108602795-B Inhibitors of metallo-beta-lactamases 牛津大学科技创新有限公司 2022-04-22 CN disclosed
US-20200375946-A1 INHIBITORS OF METALLO-BETA-LACTAMASES OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2020-12-03 US disclosed
WO-2017093727-A1 INHIBITORS OF METALLO-BETA-LACTAMASES OXFORD UNIVERSITY INNOVATION LIMITED (GB) 2017-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11439622-B2 Inhibitors of metallo-beta-lactamases IDO1, MGAM, LCT MCL1 702/4885RPA1 4544/4885KDM4E 1800/4885
US-20200375946-A1 INHIBITORS OF METALLO-BETA-LACTAMASES IDO1, MGAM, LCT MCL1 702/4885RPA1 4544/4885KDM4E 1800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.